Free-market consumer groups are pushing back against the Trump administration's effort to set a definition for ultra-processed foods, according to a letter shared first with Axios.
Why it matters: It's the latest example of a rift within the GOP base over health and nutrition policy.
Past criticism of abortion pills by President Trump's nominee to lead the Food and Drug Administration could revive an intense debate over abortion rights that the administration has largely managed to duck for the last year and a half.
Why it matters: Though the Senate is unlikely to hold a confirmation vote on White House aide Heidi Overton before the midterm elections, new talk about dialing back access to the pills could work both ways politically for Republicans.
Meta agreed to settle with U.S. states for up to $16.7 billion in a landmark deal over allegations Facebook and Instagram were designed in ways that harm children.
The company is calling on its peers to sign on to the pact as well, saying it won't work unless they jointly line up behind broad reform.
Why it matters: This is social media's version of the landmark 1990s tobacco settlement, a settlement that effectively reshapes the industry and the way young Americans experience some of their favorite platforms.
Employers' best-laid strategies for addressing steep health cost increases next year may be overly optimistic, according to a new survey the Business Group on Health released Tuesday.
Why it matters: Corporations are consistently underestimating their future costs due to extreme volatility in health markets, underscoring the need to overhaul strategies for providing worker benefits.
Missed forecasts are affecting wages and companies' ability to hire and invest in their core business, said Ellen Kelsay, president and CEO of the Business Group on Health.
